错义突变
单纯大疱性表皮松解
无义突变
遗传学
复合杂合度
大疱性表皮松解症
突变
遗传性皮肤病
杂合子丢失
人口
医学
生物
基因
等位基因
环境卫生
作者
Dan Ciubotaru,Richard N. Bergman,David Baty,Margarita Indelman,Ellen G Pfendner,Danny Petronius,Hannah Moualem,Moien Kanaan,Danny Ben Amitai,W.H. Irwin McLean,Jouni Uitto,Eli Sprecher
标识
DOI:10.1001/archderm.139.4.498
摘要
Background
Epidermolysis bullosa simplex (EBS) is the most common form of epidermolysis bullosa. The disease is characterized by intraepidermal blistering due in most cases to mutations in cytokeratin genes 5 (K5) or 14 (K14). Extensive studies in the United States and Europe have shown that EBS is almost always inherited in an autosomal dominant fashion. Objective
To assess the possibility that the molecular features of EBS may differ according to the type of population studied. Design
We assessed 10 Israeli families diagnosed as having EBS and compared their clinical and genetic features with previous observations. Affected individuals underwent complete clinical evaluation. DNA from all family members was assessed for mutations inK5orK14using polymerase chain reaction amplification, direct sequencing, and subsequent mutation verification. In addition, specific cases were genotyped using a panel of microsatellite markers spanning theK14locus. Results
Eight distinct pathogenic mutations inK5(3 mutations) andK14(5 mutations) were identified. Six of these mutations are novel. The mutations included 2 nonsense mutations and 6 missense mutations. A third of the affected families inherited EBS in a recessive fashion, in contrast with previous observations in Europe and the United States. In addition, we identified a unique case that resulted from compound heterozygosity for a missense and a nonsense mutation inK14. Homozygous nonsense mutations were strongly associated with a severe phenotype. Conclusion
The present study demonstrates a unique mutation spectrum and a strikingly different pattern of inheritance for EBS in a series of Israeli families compared with families of European or US extraction.
科研通智能强力驱动
Strongly Powered by AbleSci AI